Oro Bulletin

  • Home
  • Stocks & Business
  • Market Makers
  • Finance & Analysis
  • Contacts
  • Feedback
  • Privacy Policy
  • Comment Policy

Finance & Analysis

View More Finance & Analysis
Yokohama City University Buys Second Cray XC50-AC Supercomputer

Yokohama City University Buys Second Cray XC50-AC Supercomputer

September 22, 2017
Cray Inc. (CRAY) was unchanged in late Wednesday trading, with shares of the supercomputer manufacturer receiving...
Amphastar Pharma Gains After-Hours After Getting FDA Approval for Sodium Bicarbonate Injection

Amphastar Pharma Gains After-Hours After Getting FDA Approval for Sodium Bicarbonate Injection

September 22, 2017
Amphastar Pharma (AMPH) advanced in extended trading on Wednesday after the specialty pharmaceutical company said the...
Nikkei 225 Sheds 0.29% On Profit-Taking,

Nikkei 225 Sheds 0.29% On Profit-Taking,

September 14, 2017
Cadence Design Systems’ Entry into S&P 500 Among Index Changes Set For Next Week

Cadence Design Systems’ Entry into S&P 500 Among Index Changes Set For Next Week

September 12, 2017
Consumer Stocks Drifting With Mid-Size Declines

Consumer Stocks Drifting With Mid-Size Declines

September 11, 2017
Toshiba’s Deadline for Sale of its Chip Unit Passes Without Deal

Toshiba’s Deadline for Sale of its Chip Unit Passes Without Deal

September 01, 2017

Market Makers

View More Market Makers
Yokohama City University Buys Second Cray XC50-AC Supercomputer

Yokohama City University Buys Second Cray XC50-AC Supercomputer

September 22, 2017
Cray Inc. (CRAY) was unchanged in late Wednesday trading, with shares of the supercomputer manufacturer receiving...
Amphastar Pharma Gains After-Hours After Getting FDA Approval for Sodium Bicarbonate Injection

Amphastar Pharma Gains After-Hours After Getting FDA Approval for Sodium Bicarbonate Injection

September 22, 2017
Amphastar Pharma (AMPH) advanced in extended trading on Wednesday after the specialty pharmaceutical company said the...
Nikkei 225 Sheds 0.29% On Profit-Taking,

Nikkei 225 Sheds 0.29% On Profit-Taking,

September 14, 2017
Hong Kong Hang Seng Off 0.42% On Soft China Economic Data

Hong Kong Hang Seng Off 0.42% On Soft China Economic Data

September 14, 2017
NovoCure Says Germany’s Federal Joint Committee Supports Clinical Trial for Optune

NovoCure Says Germany’s Federal Joint Committee Supports Clinical Trial for Optune

September 07, 2017
Alnylam Pharmaceuticals Gets FDA Breakthrough Therapy Designation

Alnylam Pharmaceuticals Gets FDA Breakthrough Therapy Designation

May 31, 2017

Most Popular

  • Toshiba’s Deadline for Sale of its Chip Unit Passes Without DealToshiba’s Deadline for Sale of its Chip Unit Passes Without Deal
  • Xerox Unveils Initial Settlement of Offers to Exchange Outstanding NotesXerox Unveils Initial Settlement of Offers to Exchange Outstanding Notes
  • Landstar System Up Slightly in Late Trade After Topping Q3 Earnings Expectations; Q4 EPS Outlook Also Beats Street ViewLandstar System Up Slightly in Late Trade After Topping Q3 Earnings Expectations; Q4 EPS Outlook Also Beats Street View
  • Cadence Design Systems’ Entry into S&P 500 Among Index Changes Set For Next WeekCadence Design Systems’ Entry into S&P 500 Among Index Changes Set For Next Week
  • Stocks Stay Positive as Oil Reaches 15-Month High, Bank Earnings Beat ExpectationsStocks Stay Positive as Oil Reaches 15-Month High, Bank Earnings Beat Expectations
Copyright © All rights reserved